US Government and industry clash over COVID-19 vaccine IP waiver
The US says it will support the proposed waiver of IP protections on COVID-19 vaccines: but the country’s industry says this sets a ‘dangerous precedent for future pandemics’.
Archives for May 6, 2021
Moderna Q1 reveals COVID-19 vaccine sales stats: Biologics License Application to be submitted this month
Moderna has reported the first profitable quarter in the company’s history: after 10 years of research and several billion dollars of investment in its mRNA platform. The next step will be to start a rolling submission for a Biologics License Application...
Special Edition: Continuous bioprocessing
Continuous bioprocessing market to be worth nearly $200m within six years
A new report published by Meticulous Research shows the continuous bioprocessing market is expected to grow at a CAGR of 22.9% from 2020 to 2027 to reach US$197.8m by the end of the period.
NPD Gallery: Technology insider
What's new in the world of biopharma tech? We track the latest in process innovation equipment releases.